Cisbio Bioassays Press Releases

 
print
6/10/2009 Cisbio Bioassays Honored with the 2009 Frost & Sullivan North America Technology Innovation of the Year Award
Paradigm shifting Tag-lite™ technology platform recognized for GPCR drug discovery
5/12/2009 Cisbio Bioassays introduces Tag-lite™ Platform for the study of receptor ligand binding and dimerization
Non-radioactive, cost-effective cell surface study and screening platform reaffirms company's leading position in GPCR drug discovery research
2/25/2009 Cisbio Bioassays' IP-One Terbium assay enables measurement of different compound classes using single technology
Effective profiling of inverse agonists, agonists and antagonists of Gq-coupled receptors shows potential of assay kit, unique terbium-based technology
1/28/2009 Cisbio Bioassays selects CyBio robotic workstation to enhance custom assay development capabilities
Robust and flexible robotic workstation complements Cisbio’s expertise in creating and optimizing HTRF assays
6/16/2008 IBA finalizes acquisition of CIS BIO international by buying out the IRE's shares
4/7/2008 Cisbio Launches HTRF® Terbium Platform for GPCR Screening at SBS
IP-One Tb Assay is first product in second generation HTRF® pipeline
11/15/2007 Cisbio adopts BellBrook LABS' Transcreener platform for enhanced target screening services'
9/19/2007 Cisbio and Lumiphore Announce Partnership for New Product and Technology Development Incorporating Lumi4™ Compounds
Bagnols-sur-Cèze, France and Redwood City, CA, USA - September 5, 2007
4/16/2007 Cisbio international Announces Launch of HTRF® KinEASE™TK at SBS
Company's universal kinase assay platform expanded to address Tyrosine enzymes
10/27/2006 Cisbio international Launches New HTRF® Cell-Based Assays
Company Expands Integration of d2 Acceptor Molecule to Assays in Inflammation and Metabolic Diseases Fields
9/8/2006 Cisbio international Expands List of Serine/Threonine
Company's universal kinase assay platform now validated on 104 kinases
8/7/2006 Cisbio International Awarded $1.9 million Research Grant By France National Research Agency
Company's Intracellular Molecular Imaging Project Selected from 400 Grant Applications Highlights R&D Initiatives
5/24/2006 Cisbio international Introduces IP-One ELISA at 4th Annual GPCR Congress
Company's second IP-One assay can be used by all laboratories focused on GPCR-based targets
4/26/2006 Cisbio international Introduces IP-One Assay for GPCR-Gq High-Throughput Screening Applications
Company's HTRF Customers Deploy Novel Screening Platform for GPCR Target Validation
3/27/2006 Upstate and Cisbio international Announce Launch of HTRF® KinEASE™
New kits for rapid kinase assay development mark second product collaboration between the two companies
9/12/2005 Cisbio international Launches New cAMP Assays at SBS
Optimization of cAMP Assay Formats with d2 Acceptor Molecule Complements IP-One Assay to Enhance GPCR Platform
9/13/2004 Cisbio international Introduces New cGMP
Powerful New Kit Available for Screening Both Soluble and Particulate Guanylyl Cyclases
9/13/2004 Cisbio international Introduces Enhanced cAMP Assay Development Kit
Company Enters into Collaboration with Euroscreen for Recombinant Cell Line Validation using HTRF®
8/31/2004 Cisbio international Establishes U.S. Custom Labeling and Assay Development Facility
Company Also Appoints Mark Schmeizl to Lead North American Sales and Business Development
8/23/2004 Cisbio International Adds to HTRF® Portfolio With Introduction of Kinase and Ubiquitin Toolboxes
Company Expands Line of High-throughput Screening Solutions
8/9/2004 Cisbio international Announces Strategic Collaborations With Instrumentation Measurement Systems Developers
Company Extends HTRF® Solution to Reach High Quality Readout Levels
8/9/2004 Cisbio Announces Collaborations With Leading Reagent Developers
Company Strengthens HTRF® Technology Base for Kinase Screening Through New Partnerships